Showing below up to 50 results in range #1 to #50.
- Project:About (06:31, 24 October 2023)
- Project:Privacy Policy (06:31, 24 October 2023)
- ALCOA (10:36, 24 February 2025)
- Adverse drug reaction (10:37, 24 February 2025)
- Applicable Regulatory Requirement(s) (10:38, 24 February 2025)
- Documentation (11:30, 24 February 2025)
- Estimand (11:30, 24 February 2025)
- FDA Form 1572 (11:35, 24 February 2025)
- Impartial witness (11:37, 24 February 2025)
- Independent data-monitoring committee (11:37, 24 February 2025)
- Interim Clinical Trial (Study) Report (11:40, 24 February 2025)
- Investigator's brochure (11:42, 24 February 2025)
- Legally acceptable representative (11:42, 24 February 2025)
- Monitoring report (11:43, 24 February 2025)
- Multicentre trial (11:43, 24 February 2025)
- Nonclinical study (11:44, 24 February 2025)
- Opinion (in relation to Independent Ethics Committee) (11:44, 24 February 2025)
- Original medical record (11:45, 24 February 2025)
- Phase II clinical trials (11:46, 24 February 2025)
- Phase I clinical trials (11:46, 24 February 2025)
- Phases of clinical trials (11:47, 24 February 2025)
- Plain language summary of study results (11:48, 24 February 2025)
- Quality assurance (11:49, 24 February 2025)
- Quality control (11:50, 24 February 2025)
- Randomization (11:50, 24 February 2025)
- Regulatory authority (11:50, 24 February 2025)
- Request for Proposal (11:53, 24 February 2025)
- Functional Service Provision (11:53, 24 February 2025)
- Safety (11:53, 24 February 2025)
- Sandbox (11:54, 24 February 2025)
- Source data (11:56, 24 February 2025)
- Source documents (11:56, 24 February 2025)
- Standard operating procedures (11:57, 24 February 2025)
- Sub-investigator (11:58, 24 February 2025)
- Subject (11:58, 24 February 2025)
- Subject identification code (11:59, 24 February 2025)
- The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (11:59, 24 February 2025)
- Trial site (12:01, 24 February 2025)
- Unexpected adverse drug reaction (12:01, 24 February 2025)
- Well-being (12:02, 24 February 2025)
- Audit Trail (12:03, 24 February 2025)
- Bias (12:03, 24 February 2025)
- Bioavailability and bioequivalence requirements (12:03, 24 February 2025)
- Clinical data management (12:04, 24 February 2025)
- Clinical research (12:05, 24 February 2025)
- Clinical research regulations in the United States (12:05, 24 February 2025)
- Clinical trial (study) report (12:06, 24 February 2025)
- Codex of clinical research (12:07, 24 February 2025)
- Compassionate use (12:07, 24 February 2025)
- Compliance (12:08, 24 February 2025)